InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

- Current share price for ACL : $2.830

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$528 ASX market release - satisfaction of conditions 19 May 2021 9:01AM $3.570 $2.830 fallen by 20.73%
$528 Ceasing to be a substantial holder 19 May 2021 8:54AM $3.570 $2.830 fallen by 20.73%
$528 Change in substantial holding 19 May 2021 8:54AM $3.570 $2.830 fallen by 20.73%
$528 Change in substantial holding 19 May 2021 8:53AM $3.570 $2.830 fallen by 20.73%
$528 Satisfaction of conditions for conditional market 19 May 2021 8:50AM $3.570 $2.830 fallen by 20.73%
$528 Becoming a substantial holder 14 May 2021 5:33PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:50PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:49PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:49PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:48PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:48PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:46PM $0.011 $2.830 risen by 25,627.27%
$528 Initial Director's Interest Notice 14 May 2021 12:46PM $0.011 $2.830 risen by 25,627.27%
$528 Becoming a substantial holder 14 May 2021 12:45PM $0.011 $2.830 risen by 25,627.27%
$528 Becoming a substantial holder 14 May 2021 12:41PM $0.011 $2.830 risen by 25,627.27%
$528 Pre-quotation disclosure 14 May 2021 9:34AM $0.011 $2.830 risen by 25,627.27%
$528 Indicative top 20 holders 14 May 2021 9:34AM $0.011 $2.830 risen by 25,627.27%
$528 Indicative distribution schedule 14 May 2021 9:33AM $0.011 $2.830 risen by 25,627.27%
$528 Securities trading policy 14 May 2021 9:33AM $0.011 $2.830 risen by 25,627.27%
$528 Corporate governance statement 14 May 2021 9:32AM $0.011 $2.830 risen by 25,627.27%
$528 Rights plan rules 14 May 2021 9:31AM $0.011 $2.830 risen by 25,627.27%
$528 SunDoctors 27 December 2020 financial statements 14 May 2021 9:31AM $0.011 $2.830 risen by 25,627.27%
$528 SunDoctors 28 June 2020 financial statements 14 May 2021 9:31AM $0.011 $2.830 risen by 25,627.27%
$528 SunDoctors 30 June 2019 financial statements 14 May 2021 9:30AM $0.011 $2.830 risen by 25,627.27%
$528 SunDoctors 24 June 2018 financial statements 14 May 2021 9:30AM $0.011 $2.830 risen by 25,627.27%

651 - 675 of 1026 results

Page 27 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.